• 1. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279
• 2. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 3. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 4. Alumina coating on 5 V lithium cobalt fluorophosphate cathode material for lithium secondary batteries – synthesis and electrochemical properties?
  S. Amaresh,K. Karthikeyan,K. J. Kim,Y. S. Lee RSC Adv., 2014,4, 23107-23115
• 5. An amorphous Cu–In–S nanoparticle-based precursor ink with improved atom economy for CuInSe2 solar cells with 10.85% efficiency?
  Green Chem., 2017,19, 1268-1277

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenylmethylamines

Introduction to 3-Dimethylaminomethylbenzylamine (CAS No: 246258-97-9)

3-Dimethylaminomethylbenzylamine, identified by the Chemical Abstracts Service Number (CAS No) 246258-97-9, is a significant organic compound with a broad spectrum of applications in the field of pharmaceuticals and chemical synthesis. This compound belongs to the class of amines and features a benzyl group substituted with a dimethylamino moiety, which contributes to its unique chemical properties and reactivity. The structural arrangement of this molecule makes it a valuable intermediate in the synthesis of various bioactive molecules, particularly in medicinal chemistry.

The structure of 3-Dimethylaminomethylbenzylamine consists of a phenyl ring attached to a secondary amine functional group, where the nitrogen atom is further substituted with two methyl groups. This configuration imparts both basicity and steric hindrance, influencing its interaction with other molecules. The benzyl group, derived from benzyl alcohol, enhances its solubility in organic solvents and facilitates its role as a protecting group or linking agent in synthetic pathways.

In recent years, 3-Dimethylaminomethylbenzylamine has garnered attention in the pharmaceutical industry due to its utility as a building block for more complex drug molecules. Its ability to form stable amide and urea bonds makes it particularly useful in the synthesis of peptide mimetics and protease inhibitors. These applications are critical in the development of treatments for various diseases, including cancer and infectious disorders.

One of the most compelling aspects of 3-Dimethylaminomethylbenzylamine is its role in drug discovery and development. Researchers have leveraged its structural features to create novel compounds with enhanced pharmacological properties. For instance, derivatives of this compound have been investigated for their potential as kinase inhibitors, which are essential in targeting signaling pathways involved in tumor growth and progression. The dimethylamino group enhances binding affinity by forming hydrogen bonds and dipole-dipole interactions with target proteins.

Moreover, the compound's versatility extends to its use as a chiral auxiliary in asymmetric synthesis. Chirality plays a crucial role in the efficacy and safety of many drugs, as enantiomers can exhibit vastly different biological activities. 3-Dimethylaminomethylbenzylamine has been employed to induce stereochemical control during the synthesis of optically active molecules, ensuring that pharmaceuticals retain their desired therapeutic profiles.

Recent advancements in medicinal chemistry have highlighted the importance of 3-Dimethylaminomethylbenzylamine in designing next-generation therapeutics. For example, studies have demonstrated its utility in creating constrained peptides that mimic natural bioactive peptides but with improved stability and bioavailability. These constrained peptides are being explored for applications ranging from anti-inflammatory agents to neuroprotective drugs.

The compound's reactivity also makes it valuable in catalysis and organic transformations. It can serve as a ligand or intermediate in transition metal-catalyzed reactions, facilitating cross-coupling reactions such as Suzuki-Miyaura couplings. These reactions are fundamental in constructing complex molecular architectures required for advanced pharmaceuticals.

In conclusion, 3-Dimethylaminomethylbenzylamine (CAS No: 246258-97-9) represents a cornerstone compound in modern chemical synthesis and pharmaceutical research. Its unique structural features enable diverse applications, from drug development to catalytic processes, underscoring its importance in advancing scientific innovation. As research continues to uncover new methodologies and targets, the role of this compound is expected to expand further, contributing to breakthroughs across multiple disciplines.

• 4788-37-8(N-Ethyl-N-methylbenzylamine)
• 1875-92-9(Benzenemethanamine,N,N-dimethyl-, hydrochloride (1:1))
• 14800-26-1(Benzenemethanaminium,N,N-dimethyl-N-(phenylmethyl)-)
• 102-05-6(Dibemethine)
• 10479-25-1(N-Ethyldibenzylamine)
• 14800-24-9(Benzenemethanaminium,N,N,N-trimethyl-)
• 16846-81-4(1,4-Benzenedimethanaminium,N1,N1,N1,N4,N4,N4-hexamethyl-, bromide (1:2))
• 772-54-3(N-Benzyldiethylamine-d4)
• 16652-03-2(Benzenemethanaminium,N,N,N-triethyl-)
• 111865-47-5(Benzyl trimethyl ammonium tribromide)